Mesenchymal chondrosarcoma: An Australian multi‐centre cohort study

BACKGROUND: Mesenchymal chondrosarcoma (MCS) is an ultra‐rare sarcoma that follows a more aggressive course than conventional chondrosarcoma. This study evaluates prognostic factors, treatments (surgery, chemotherapy, and radiation), and outcomes in an Australian setting. METHODS: We collected demog...

Descripción completa

Detalles Bibliográficos
Autores principales: Strach, Madeleine C., Grimison, Peter S., Hong, Angela, Boyle, Richard, Stalley, Paul, Karim, Rooshdiya, Connolly, Elizabeth A., Bae, Susie, Desai, Jayesh, Crowe, Philip, Singhal, Nimit, Bhadri, Vivek A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844591/
https://www.ncbi.nlm.nih.gov/pubmed/35603739
http://dx.doi.org/10.1002/cam4.4849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844591/
https://www.ncbi.nlm.nih.gov/pubmed/35603739
http://dx.doi.org/10.1002/cam4.4849

Ejemplares similares